|
Volumn 189, Issue 4 SUPPL., 2003, Pages
|
Menopausal hormone therapy informed consent
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
ALPHA TOCOPHEROL;
ANGELICA SINENSIS EXTRACT;
CALCIUM;
CLONIDINE;
ESTROGEN;
FLUOXETINE;
GESTAGEN;
IPRIFLAVONE;
LUBRICATING AGENT;
NORADRENALIN UPTAKE INHIBITOR;
PAROXETINE;
PHYTOESTROGEN;
PRIMROSE OIL;
RALOXIFENE;
RISEDRONIC ACID;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
SOYBEAN PROTEIN;
VENLAFAXINE;
VITAMIN D;
BREAST CANCER;
CANCER RISK;
CLINICAL TRIAL;
CLOVER;
COLORECTAL CANCER;
DEMENTIA;
DOCTOR PATIENT RELATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MEGADOSE;
EDITORIAL;
FEMALE;
FRAGILITY FRACTURE;
HORMONAL THERAPY;
HOT FLUSH;
HUMAN;
INFORMED CONSENT;
ISCHEMIC HEART DISEASE;
LUNG EMBOLISM;
MEDICAL DECISION MAKING;
MENOPAUSAL SYNDROME;
MENOPAUSE;
NIGHT SWEAT;
OSTEOPOROSIS;
PATIENT EDUCATION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RED CLOVER;
RISK BENEFIT ANALYSIS;
STROKE;
URINE INCONTINENCE;
VAGINA DISEASE;
XEROSIS;
|
EID: 0242643736
PISSN: 00029378
EISSN: None
Source Type: Journal
DOI: 10.1067/S0002-9378(03)01097-4 Document Type: Article |
Times cited : (3)
|
References (7)
|